Cargando…

Factor B and C4b2a Autoantibodies in C3 Glomerulopathy

C3 Glomerulopathy (C3G) is a renal disease mediated primarily by dysregulation of the alternative pathway of complement. Complement is the cornerstone of innate immunity. It targets infectious microbes for destruction, clears immune complexes, and apoptotic cells from the circulation, and augments t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauer, Jill J., Shao, Dingwu, Zhang, Yuzhou, Nester, Carla M., Smith, Richard J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460050/
https://www.ncbi.nlm.nih.gov/pubmed/31024533
http://dx.doi.org/10.3389/fimmu.2019.00668
_version_ 1783410277221400576
author Hauer, Jill J.
Shao, Dingwu
Zhang, Yuzhou
Nester, Carla M.
Smith, Richard J. H.
author_facet Hauer, Jill J.
Shao, Dingwu
Zhang, Yuzhou
Nester, Carla M.
Smith, Richard J. H.
author_sort Hauer, Jill J.
collection PubMed
description C3 Glomerulopathy (C3G) is a renal disease mediated primarily by dysregulation of the alternative pathway of complement. Complement is the cornerstone of innate immunity. It targets infectious microbes for destruction, clears immune complexes, and apoptotic cells from the circulation, and augments the humoral response. In C3G, this process becomes dysregulated, which leads to the deposition of complement proteins—including complement component C3—in the glomerular basement membrane of the kidney. Events that trigger complement are typically environmental insults like infections. Once triggered, in patients who develop C3G, complement activity is sustained by a variety of factors, including rare or novel genetic variants in complement genes and autoantibodies that alter normal complement protein function and/or regulation. Herein, we review two such autoantibodies, one to Factor B and the other to C4b2a, the C3 convertase of the classical, and lectin pathways. These two types of autoantibodies are identified in a small fraction of C3G patients and contribute marginally to the C3G phenotype.
format Online
Article
Text
id pubmed-6460050
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64600502019-04-25 Factor B and C4b2a Autoantibodies in C3 Glomerulopathy Hauer, Jill J. Shao, Dingwu Zhang, Yuzhou Nester, Carla M. Smith, Richard J. H. Front Immunol Immunology C3 Glomerulopathy (C3G) is a renal disease mediated primarily by dysregulation of the alternative pathway of complement. Complement is the cornerstone of innate immunity. It targets infectious microbes for destruction, clears immune complexes, and apoptotic cells from the circulation, and augments the humoral response. In C3G, this process becomes dysregulated, which leads to the deposition of complement proteins—including complement component C3—in the glomerular basement membrane of the kidney. Events that trigger complement are typically environmental insults like infections. Once triggered, in patients who develop C3G, complement activity is sustained by a variety of factors, including rare or novel genetic variants in complement genes and autoantibodies that alter normal complement protein function and/or regulation. Herein, we review two such autoantibodies, one to Factor B and the other to C4b2a, the C3 convertase of the classical, and lectin pathways. These two types of autoantibodies are identified in a small fraction of C3G patients and contribute marginally to the C3G phenotype. Frontiers Media S.A. 2019-04-04 /pmc/articles/PMC6460050/ /pubmed/31024533 http://dx.doi.org/10.3389/fimmu.2019.00668 Text en Copyright © 2019 Hauer, Shao, Zhang, Nester and Smith. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Hauer, Jill J.
Shao, Dingwu
Zhang, Yuzhou
Nester, Carla M.
Smith, Richard J. H.
Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
title Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
title_full Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
title_fullStr Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
title_full_unstemmed Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
title_short Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
title_sort factor b and c4b2a autoantibodies in c3 glomerulopathy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460050/
https://www.ncbi.nlm.nih.gov/pubmed/31024533
http://dx.doi.org/10.3389/fimmu.2019.00668
work_keys_str_mv AT hauerjillj factorbandc4b2aautoantibodiesinc3glomerulopathy
AT shaodingwu factorbandc4b2aautoantibodiesinc3glomerulopathy
AT zhangyuzhou factorbandc4b2aautoantibodiesinc3glomerulopathy
AT nestercarlam factorbandc4b2aautoantibodiesinc3glomerulopathy
AT smithrichardjh factorbandc4b2aautoantibodiesinc3glomerulopathy